Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CoTec Holdings Corp T.CTH


Primary Symbol: V.CTH Alternate Symbol(s):  CTHCF

CoTec Holdings Corp. is a Canada-based environment, social, and governance (ESG)-focused company investing in technologies. The Company focuses on investment in disruptive and scalable technology in the mineral extraction industry and, in parallel, acquiring assets to which the technology could be applied. It supports the transition to a lower carbon future for the extraction industry. It invests in, licenses and owns technologies that are transformative, disruptive and result in lower carbon footprints than existing processes for extracting, refining and processing metals and minerals. Its initial focus is acquiring stakes in multiple technologies, which are disruptive and scalable. Through licensing, joint ventures and operations, it applies its acquired technology interests and rights to assets in multiple commodities. These assets range from traditional mines to waste dumps and recycled scrap.


TSXV:CTH - Post by User

Post by cedarguyon Mar 31, 2015 10:12am
354 Views
Post# 23581011

Financing - some heavy hitters

Financing - some heavy hitters
 Cynapsus Therapeutics Announces CAD$21 Million Private Placement bwire TORONTO (Business Wire) -- Cynapsus Therapeutics Inc. (TSX:CTH) (OTCQX:CYNAF), a specialty  pharmaceutical company focused on the treatment of OFF episodes in  Parkinson's disease, today announced the completion of a private  placement (the "Offering") of 22,039,472 common shares of the Company  (the "Common Shares") for gross proceeds of CAD$20,981,579. The financing was led by funds associated with OrbiMed, Aisling Capital  and Venrock, with participation from various other institutional  investors, including existing shareholders Broadfin Capital, Sphera  Funds Management, Pura Vida Investments, DAFNA Capital Management and  Dexcel Pharma Technologies Ltd./Dexxon Holdings Ltd ("Dexcel"). "We greatly appreciate the confidence shown by such high-quality life  science investors in leading this financing," commented Anthony  Giovinazzo, Cynapsus' President and Chief Executive Officer. "This fund  raise provides us with further resources to undertake our Phase 3  clinical studies in the United States, file an expected New Drug  Application in 2016, and continue with our strategic objectives." Details of the Offering Each Common Share was issued at a price of CAD$0.95 (the "Issue Price"),  which represents a 20% discount to the 5-day volume-weighted average  price per Common Share on the Toronto Stock Exchange (the "TSX") as of  the close of business on March 27, 2015. The Common Shares issued are  subject to a hold period, which will expire four months plus one day  from the date of issue.
<< Previous
Bullboard Posts
Next >>